Previous Close | 4.0600 |
Open | 4.0800 |
Bid | 4.3700 x 600 |
Ask | 4.4000 x 1000 |
Day's Range | 4.0650 - 4.5000 |
52 Week Range | 1.5000 - 5.2200 |
Volume | |
Avg. Volume | 2,224,364 |
Market Cap | 3.082B |
Beta (5Y Monthly) | -1.20 |
PE Ratio (TTM) | 11.55 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
MIAMI, May 01, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on its operational progress for the first quarter ended March 31, 2024.
MIAMI, April 24, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its first quarter 2024 financial results and provide an operational update for the Company on Wednesday, May 1, 2024, before the market opens.
MIAMI, April 11, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that Mostafa Ronaghi, PhD, has been appointed to its Board of Directors, effective immediately.